All individual trials at Celyad Oncology SA

An AllTrials project

All individual trials at Celyad Oncology SA

2 out of 2

100.0%

$3,621,097

$0

Status	Sponsor	Trial ID	Title	Completion date	Days overdue
reported-late	Celyad Oncology SA	NCT03466320	An Open-label, Phase I/II Study to Assess the Safety and Clinical Activity of NKR-2 Treatment Administration After a Non-myeloablative Preconditioning Chemotherapy in Relapse/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients.	2021-02-01	238
reported-late	Celyad Oncology SA	NCT03018405	A Multi-national, Open-label, Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Administrations of NKR-2 in Patients With Different Metastatic Tumor Types (THINK - THerapeutic Immunotherapy With NKR-2) [pACT]	2021-05-31	135

Download this data